• العربية
    • Biotricity, Healthcare

    Biotricity unveils that improved margins resulted from latest advancements to its proprietary cardiac AI cloud platform and announces plans for continued expansion of its cardiac AI cloud

    March 12, 2024

    Biotricity Inc. (Biotricity) announces the expansion of its Cardiac AI Cloud platform: the company is building a cardiac AI clinical model which distills important information to support clinician in cases that require clinical intervention or review. The company expects to file an FDA clearance for its clinical model by the end of the year.

    Recent Posts

    Recent Comments

    No comments to show.
    Recent Posts
    Archives
    Categories
    Meta
    Previous
    Biotricity accelerates market access by partnering with third major group purchasing organization, expanding market reach to 90% of U.S. hospitals
    Next
    Biotricity partners with a second top group purchasing organization – positions company for expanded market access to 1 out of every 2 hospitals in America
    Privacy Settings
    We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please check our Privacy Policy
    Youtube
    Consent to display content from - Youtube
    Vimeo
    Consent to display content from - Vimeo
    Google Maps
    Consent to display content from - Google
    Spotify
    Consent to display content from - Spotify
    Sound Cloud
    Consent to display content from - Sound
    Save